Teva Plans To Take Skinny-Label Defeat To Supreme Court

Company Confirms It Will Seek Review Of GSK Labeling Carve-Outs Litigation In US

Supreme Court long shot
Teva is seeking Supreme Court review of the litigation
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

More from Legal & IP

More from Generics Bulletin